These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6184988)

  • 1. Clinical and immunologic response to antigen-specific transfer factor in drug-resistant infection with Mycobacterium xenopi.
    Dwyer JM; Gerstenhaber BJ; Dobuler KJ
    Am J Med; 1983 Jan; 74(1):161-8. PubMed ID: 6184988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin sensitivity of adults on the Isthmus of Panama to Mycobacterium xenopi sensitin.
    Larrabee WF; Talavera R
    Am J Trop Med Hyg; 1979 Jan; 28(1):106-9. PubMed ID: 434302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity.
    Metcalf JF; John JF; Wilson GB; Fudenberg HH; Harley RA
    Am J Med; 1981 Sep; 71(3):485-92. PubMed ID: 7025623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Mycobacterium xenopi in human disease.
    Simor AE; Salit IE; Vellend H
    Am Rev Respir Dis; 1984 Mar; 129(3):435-8. PubMed ID: 6703502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi.
    Costrini AM; Mahler DA; Gross WM; Hawkins JE; Yesner R; D'Esopo ND
    Am Rev Respir Dis; 1981 Jan; 123(1):104-9. PubMed ID: 7458072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor treatment in a patient with progressive tuberculosis.
    Rubinstein A; Melamed J; Rodescu D; Murphy RA; Broocker D
    Clin Immunol Immunopathol; 1977 Jul; 8(1):39-50. PubMed ID: 301805
    [No Abstract]   [Full Text] [Related]  

  • 7. [Two cases of pulmonary Mycobacterium xenopi infection].
    Yamazaki Y; Fujiuchi S; Matsumoto H; Takahashi T; Takeda A; Fujita Y; Fujikane T; Shimizu T; Nishigaki Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Aug; 41(8):556-60. PubMed ID: 14503343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
    Wilson GB; Fudenberg HH; Keller RH
    J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfer factor therapy in a patient with anergic pulmonary tuberculosis].
    Kind CH; Gartmann JC; Grob PJ
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1742-3. PubMed ID: 929133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemical nature of the antigen-specific moiety of transfer factor.
    Wilson GB; Paddock GV; Fudenberg HH
    Trans Assoc Am Physicians; 1979; 92():239-56. PubMed ID: 95068
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycobacterium xenopi pneumonia in the southeastern United States.
    Faress JA; McKinney LA; Semaan MT; Byrd RP; Mehta JB; Roy TM
    South Med J; 2003 Jun; 96(6):596-9. PubMed ID: 12938788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical mycobacterium infection treated with dialyzable leukocyte extracts: evidence for antigenic specificity.
    Simon MR; Salberg DJ; Silva J; Ganji S; Desai S; Muller BF; Palutke M
    Clin Immunol Immunopathol; 1981 Jul; 20(1):123-8. PubMed ID: 6167387
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
    Schmitt H; Schnitzler N; Riehl J; Adam G; Sieberth HG; Haase G
    Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin reactivity to mycobacterial antigens in children living in an area of Mycobacterium xenopi endemicity.
    Kubín M; Svandová E; Stastná J
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):327-33. PubMed ID: 3680941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy of advanced pulmonary tuberculosis with specific transference factor].
    Estrada Parra S; Velasco Castrejón O; Rébora F; Díaz ML; Padierna J
    Salud Publica Mex; 1983; 25(6):579-90. PubMed ID: 6665598
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis.
    Kadival GV; Chaparas SD; Hussong D
    J Immunol; 1987 Oct; 139(7):2447-51. PubMed ID: 2443566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pott's disease caused by Mycobacterium xenopi: case report and review.
    Miller WC; Perkins MD; Richardson WJ; Sexton DJ
    Clin Infect Dis; 1994 Dec; 19(6):1024-8. PubMed ID: 7888528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review.
    Varadi RG; Marras TK
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1210-8. PubMed ID: 19793424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.